ORTEXORTEX News
Tracking S? Get live short interest, options flow, and signals on ORTEX.Sign up free →
S
ConfluenceS

Bernstein Downgrades SentinelOne Despite Price Target Hike

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 17 Sept 2026, 12:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Bernstein's Peter Weed cut S to Market Perform from Outperform today — while simultaneously raising his price target to $25 from $21. The mixed signal lands as short sellers quietly build positions and the broader cybersecurity sector rallies hard.

The Downgrade That Isn't Quite Bearish

The Bernstein move is the headline. A downgrade paired with a 19% target increase is unusual. It signals Weed sees the stock as fairly valued after a sharp run — not deteriorating fundamentally. S gained 19.2% over the past week alone, tracking peers like RPD (+18.0%), NTSK (+19.6%), and CRWD (+16.2%).

The analyst consensus still sits at "buy," with 16 buy ratings against 15 holds. The mean price target is $24.38 — just above Tuesday's close of $23.17. That tight gap between price and consensus target helps explain Bernstein's caution.

Wedbush assumed coverage on September 11 with an Outperform and a $25 target, pulling in the opposite direction.

Short Interest Climbs Into the Rally

Short sellers added positions through the surge. SI rose 13% over the past week to 5.9% of free float. That is the highest level in recent sessions, though still within a moderate range for a growth cybersecurity name.

The borrow market tells a calmer story. Cost to borrow sits at 0.24% — down sharply from 0.44% a month ago. Availability is exceptionally loose at 1,762% — meaning roughly 18 shares are available to borrow for every one already lent out. There is no meaningful squeeze pressure here. Shorts are adding into a stock with a deep, liquid lending pool.

Insider Sales Add a Layer of Caution

The 90-day net insider position is -$10.8 million. CEO Tomer Weingarten sold 114,890 shares on September 11 at $19.89 for approximately $2.3 million. He also sold 38,759 shares on September 8 at $19.79 — that second transaction carries no 10b5-1 plan, meaning it was a discretionary sale. CFO Sonalee Elizabeth Parekh and Chief Legal Officer Keenan Conder also sold in the same window. The CLO's September 8 sale was similarly not under a pre-arranged plan.

Discretionary insider sales into a strong run are worth noting. They don't override analyst views, but they add texture.

Data Summary

  • Bernstein action: Downgrade to Market Perform; PT raised to $25 from $21
  • Consensus: 16 buy, 15 hold; mean PT $24.38
  • 1-week price change: +19.2%
  • SI % of free float: 5.9%, up 13% week-on-week
  • Cost to borrow: 0.24%, down ~43% over one month
  • Borrow availability: 1,762% — very loose
  • 90-day net insider value: -$10.8M; two discretionary sales on Sept. 8
  • Next earnings: December 4, 2026

Stocks in this article

See the live data behind this article on ORTEX.

Open S on ORTEX →

How this article was generated

Generated
17 Sept 2026, 12:04
Data as of
17 Sept 2026, 12:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.